FDA Funding Situation Puts Agency Mission "At Risk," Says Alliance President

Alliance President Diane Dorman, giving testimony today to the Science Board of the U.S. Food and Drug Administration, stated that the Alliance believes the agency's historic mission is again "at risk" due to severe underfunding and increasing responsibilities legislated by Congress. The complete text of Ms. Dorman's testimony is available on this web site.